About
About us
Our methods
Updated report
Multilinguality
Help
How to use
Key concepts
FAQ
Contact
Sign up
Login
العربية
Deutsch
English
Español
Français
Italiano
Nederlands
Português
中文
×
Email:
Password:
Forgot Password
×
Edit Thread Title
Thread name
Thread full name
Thread alternative names
Thread phase
×
Delete Thread
Are you sure you want to delete the thread
? This operation cannot be undone.
GW Pharmaceuticals Ltd [provisional name]
(Sativex for central neuropathic pain due to spinal cord injury [provisional name])
ID:
55a8304f18d84e7113b97dcd
2 Documents
Export all
Document ID
Add to Thread
Thread ID
Merge thread
Close
2 References
( articles)
Revert
Studify
Primary study
Unclassified
A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
Authors
»
Jazz Pharmaceuticals
Registry of Trials
»
clinicaltrials.gov
Year
»
2002
Links
»
Registry of Trials
Loading references information
No abstract
Show abstract
A study to investigate the effects of sublingual cannabis based medicine extracts on neuropathic pain associated with spinal cord injury.
Hide abstract
Primary study
Unclassified
Sativex in the treatment of central neuropathic pain due to spinal cord injury: a randomised controlled study
Authors
»
Berman, J
,
Bosworth, T
,
Guy, G
,
Stott, C
,
Group, Sativex Spinal Cord Injury Study
Conference
»
British Pain Society Annual Scientific Meeting
Year
»
2007
Loading references information
No abstract
Show abstract
Hide abstract
Abstract
About this article
Related evidence
A study to investigate the effects of sublingual cannabis based medicine extracts on neuropathic pain associated with spinal cord injury.
Study Design
»
Randomized controlled trial (RCT)
Country
»
United Kingdom
